LEPORATI, RITA
LEPORATI, RITA
Universita' degli Studi di MILANO
Mostra
records
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.003 secondi).
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications
2020 E. Zattarin, R. Leporati, F. Ligorio, R. Lobefaro, A. Vingiani, G. Pruneri, C. Vernieri
The pan-immune-inflammation-value predicts the survival of patients with human epidermal growth factor receptor 2 (Her2)—positive advanced breast cancer treated with first-line taxane-trastuzumab-pertuzumab
2021 F. Ligorio, G. Fuca, E. Zattarin, R. Lobefaro, L. Zambelli, R. Leporati, C. Rea, G. Mariani, G.V. Bianchi, G. Capri, F. de Braud, C. Vernieri
| Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
|---|---|---|---|---|---|
| Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications | 1-gen-2020 | Zattarin, ELeporati, RLigorio, FLobefaro, RVingiani, APruneri, GVernieri, C | Article (author) | - | |
| The pan-immune-inflammation-value predicts the survival of patients with human epidermal growth factor receptor 2 (Her2)—positive advanced breast cancer treated with first-line taxane-trastuzumab-pertuzumab | 1-apr-2021 | Ligorio F.Zattarin E.Lobefaro R.Zambelli L.Leporati R.de Braud F. + | Article (author) | - |